《大行報告》瑞銀上調新秀麗(01910.HK)目標價至35.4元 評級「買入」
新秀麗(01910.HK)將於11月中旬公布第三季業績,瑞銀發表報告料其第三季調整後EBITDA達1.88億美元;公司早前將今年營銷支出比率指引由原先6.5%上調至介乎6.5%至7%,但該行表示,基於第三季營銷活動較靜,該行料第三季營銷支出或按季走低。
另瑞銀料新秀麗第三季毛利率較上半年持平,主要是批發渠道的銷售回升。該行預料,公司第三季調整後EBITDA利潤率達19.7%,高於市場預期的19%,並將其目標價由34.4元上調至35.4元,維持其評級為「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.